GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced ... may cut that risk by nearly 50% — an approach that would ...

Caroline Manzo’s daughter, Lauren Manzo, admitted she used the weight-loss drug Mounjaro, a competitor of Ozempic, to lose 30 pounds following a 50-pound weight loss. “You guys have seen me ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

There was one clear winner. Mounjaro helped people achieve 50% more weight loss than Ozempic. Those taking Mounjaro lost on average 20% of their body weight. In that same period, patients using ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.